AI Article Synopsis

  • A 25-year-old male exhibited symptoms of a hypertensive storm due to pheochromocytoma, a rare tumor affecting the adrenal glands.
  • His condition was initially misdiagnosed, as doctors overlooked the underlying cause of his persistent high blood pressure over several years.
  • Notable features included early onset of symptoms, fluctuating blood pressure, signs of Marfan's syndrome, elevated troponin levels during hypertension, and episodes of proteinuria and glycosuria without high blood sugar.

Article Abstract

The case of 25 years old male patient with symptoms of hypertensive storm in the course of pheochromocytoma was presented. For some years he had been suffering from moderate increase in arterial blood pressure whose secondary cause was not suspected by physicians examining this patient. In presented case the course of pheochromocytoma has special characteristics, such as: clinical presentation in young age, the course alternate between periods of hypertension and phases of normal blood pressure, physical signs of Marfan's syndrome, increase of troponin level within hypertensive storm, and attributes of malignant hypertension presented as transient proteinuria and glycosuria within normoglycemia.

Download full-text PDF

Source

Publication Analysis

Top Keywords

hypertensive storm
8
course pheochromocytoma
8
blood pressure
8
[pheochromocytoma--a disease
4
disease worth
4
worth mind]
4
mind] case
4
case years
4
years male
4
male patient
4

Similar Publications

Coronavirus disease 2019 (COVID-19) has been a global pandemic affecting millions of people's lives, which has led to 'post-COVID-19 fatigue'. Alarmingly, severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) not only infects the lungs but also influences the heart and brain. Endothelial cell dysfunction and hypercoagulation, which we know occur with this infection, lead to thrombo-inflammation that can manifest as many myriad cardio-cerebrovascular disorders, such as brain fog, fatigue, cognitive dysfunction, etc.

View Article and Find Full Text PDF

The occurrence of post-radioactive iodine thyroid storm among patients with hyperthyroidism is relatively rare and only a few cases have been reported. We conducted a literature review of cases reported from 1951 to 2023 and determined the risk factors and clinical characteristics of patients who developed thyroid storm. A total of 19 cases were documented and reviewed.

View Article and Find Full Text PDF
Article Synopsis
  • Acute coronary syndrome (ACS) is common in COVID-19 patients, potentially linked to high levels of interleukin-6 (IL-6) that contribute to heart injury.
  • *A study analyzed data from 1,753 hospitalized COVID-19 patients, finding ACS patients were older with more health issues, including diabetes and hypertension.
  • *Key indicators like IL-6, D-dimer, and troponin were significantly higher in ACS patients, suggesting these factors can help predict ACS risk in COVID-19 cases.
View Article and Find Full Text PDF
Article Synopsis
  • Pheochromocytomas can be hard to diagnose since they don't always present with the classic symptoms of headaches, palpitations, and high blood pressure; only about 25% of cases show this triad.
  • A 41-year-old woman experienced a heart attack with no blocked arteries and was later diagnosed with pheochromocytoma, but her condition worsened due to erratic blood pressure and complications like a thyroid storm, leading to her death.
  • It’s crucial for doctors to consider pheochromocytoma and thyroid issues in patients with non-obstructive heart attacks, as early detection could improve survival rates, even though current guidelines don't highlight these conditions as potential causes.
View Article and Find Full Text PDF

Bipolar radiofrequency ablation of refractory ventricular arrhythmias: results from a multicentre network.

Europace

October 2024

Cardioangiologisches Centrum Bethanien, Department Kardiologie, Markus Krankenhaus, Frankfurt, Germany.

Article Synopsis
  • Advanced bipolar radiofrequency catheter ablation (Bi-RFA) is being studied as a new treatment for patients with ventricular tachycardia (VT) and premature ventricular contractions (PVC) that do not respond to standard unipolar radiofrequency ablation (Uni-RFA).
  • A multicenter registry conducted in Europe showed that out of 91 patients treated with Bi-RFA, 74% achieved elimination of clinical VT/PVC, and 78% experienced a significant reduction in PVC burden during follow-up.
  • The procedure was found to be generally safe and feasible, though there were some major complications reported, indicating that Bi-RFA could be a valid option for managing refractory VT/PVC
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!